Our Portfolio Company Biome Diagnostics, a healthcare startup that specializes in diagnostic tools for microbiome analysis reached the finals at the EIT Health Catapult program. The program is a unique competition and training programm for healthcare startups in Europe. Never before have so many companies applied as this year. We are so proud that Biome Diagnostics’ innovative approach to microbiome analysis convinces the judges.

The road to the finals

The BiomeDx team has been working tirelessly in the last few years to develop cutting-edge diagnostic tools for microbiome analysis. Their efforts have paid off! The jury selected them as one of the top healthcare startups in Europe. They applied, got selected, passed regional selections and received further training. After successfully passing the semifinals, BiomeDx are thrilled to have made it to the final round. The team around the founders Barbara Sladek and Nikolaus Gasche is now looking forward to presenting their technology at the finals in Munich.

Being part of the EIT Health Catapult program has obviously provided BiomeDx with a unique opportunity to connect with other innovative startups, industry experts, and investors. They received valuable insights and feedback, which they will use to further improve their technology.

The company believes that their innovative approach that microbiome analysis has undoubtedly the potential to revolutionize personalized medicine. They are excited to share their vision with the EIT Health Catapult community and grateful for the opportunity to showcase their technology.

Mking it to the finals of the EIT Health Catapult program is a testament to their hard work. Furthermore it proofs their dedication to developing revolutionary diagnostic tools for microbiome analysis.

We send our warmest congratulations on reaching the finals. We cross our fingers – you will for sure rock this!